Gastrointestinal Cancer Market By Cancer Type (Colorectal Cancer, Stomach Cancer, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Others), By Treatment (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery, Others), By Diagnostics (Endoscopy, Biopsy, Molecular Diagnostics, Imaging, Others), By End-User (Hospitals, Oncology Centers, Research Institutes, Diagnostic Laboratories), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035.

Report Coverage:

By Cancer Type

• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer
• Liver Cancer
• Others

By Treatment

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy
• Surgery
• Others

By Diagnostics

• Endoscopy
• Biopsy
• Molecular Diagnostics
• Imaging
• Others

By End-user

• Hospitals
• Oncology Centers
• Research Institutes
• Diagnostic Laboratories
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Ferring Holding SA
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Roche Holding AG
• AstraZeneca PLC
• Amgen Inc.
• Novartis AG
• Sanofi S.A.
• Pfizer Inc.
• Johnson & Johnson
• Celgene Corporation
• Regeneron Pharmaceuticals, Inc.
• Exelixis, Inc.